Control Bionics Ltd (CBL)

Sydney
Currency in AUD
Disclaimer
0.041
0.000(0.00%)
Closed
Day's Range
0.0410.041
52 wk Range
0.0370.195
Bid/Ask
0.038 / 0.042
Prev. Close
0.041
Open
0.041
Day's Range
0.041-0.041
52 wk Range
0.037-0.195
Volume
77,593
Average Volume (3m)
115,243
1-Year Change
-72.67%
Shares Outstanding
117,924,171
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
0.090
Upside +119.512%
How do you feel today about CBL?
Vote to see community's results!
or

Control Bionics Ltd Company Profile

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.